US2019112642A1PendingUtilityA1
Measuring method for amplicon length
Est. expiryAug 24, 2035(~9.1 yrs left)· nominal 20-yr term from priority
C12Q 1/6851C12Q 1/6818C12Q 1/6869
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A measuring method for amplicon length is provided. A qPCR master mix, a forward primer, a reverse primer, a hybridization probe, a double-stranded DNA binding dye, and nucleic acid samples are added into reaction wells for qPCR reaction, and the fluorescence intensity of each of a hybridization probe and a double-stranded DNA binding dye varying with cycle number is respectively measured. Afterwards, amplicon length is obtained by applying a calculating method.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A measuring method for amplicon length, comprising:
mixing a qPCR master mix, a forward primer, a reverse primer, a hybridization probe, a double-stranded DNA binding dye, and nucleic acid samples to form a qPCR reaction mixture; distributing the qPCR reaction mixture in reaction wells of a test slide, wherein no more than one of the nucleic acid samples is distributed in each of the reaction wells; performing a qPCR reaction on the qPCR reaction mixture to respectively measure the fluorescence intensity of each of the hybridization probe and the double-stranded DNA binding dye of each amplicon in the nucleic acid samples varying with cycle number; and applying a calculating method to calculate a length of each of the amplicons.
2 . The method of claim 1 , wherein the calculating method comprises:
respectively converting the fluorescence intensity of the double-stranded DNA binding dye and the fluorescence intensity of the hybridization probe measured for each of the amplicons into a normalized fluorescence intensity of the double-stranded DNA binding dye and a normalized fluorescence intensity of the hybridization probe; dividing the normalized fluorescence intensity of the double-stranded DNA binding dye and the normalized fluorescence intensity of the hybridization probe of each of the amplicons by each other to obtain a fluorescence intensity ratio; and substituting the fluorescence intensity ratio of each of the amplicons at the threshold cycle number in a linear regression curve of fluorescence intensity ratio and amplicon length to calculate the length of each of the amplicons.
3 . The method of claim 2 , wherein the converting method of the normalized fluorescence intensity of the double-stranded DNA binding dye and the normalized fluorescence intensity of the hybridization probe comprises:
dividing the fluorescence intensity of the double-stranded DNA binding dye at each cycle by an average fluorescence intensity of the double-stranded DNA binding dye in a cycle interval to obtain the normalized fluorescence intensity of the double-stranded DNA binding dye; and dividing the fluorescence intensity of the hybridization probe at each cycle by the average fluorescence intensity of the hybridization probe in the cycle interval to obtain the normalized fluorescence intensity of the hybridization probe.
4 . The method of claim 1 , wherein the double-stranded DNA binding dye comprises an SYBR Green dye, an Eva Green dye, an LC Green dye, or an SYTO 9 dye.
5 . The method of claim 1 , wherein the qPCR master mix comprises a reaction buffer, dNTP, MgCl 2 , and Taq polymerase.
6 . The method of claim 1 , wherein a concentration of the double-stranded DNA binding dye in the qPCR reaction mixture is 1 uM to 10 uM.
7 . The method of claim 1 , wherein a concentration of the hybridization probe in the qPCR reaction mixture is 0.2 uM to 1 uM.
8 . The method of claim 1 , wherein a concentration of the forward primer in the qPCR reaction mixture is 0.03 uM to 0.5 uM, and a concentration of the reverse primer in the qPCR reaction mixture is 0.03 uM to 0.5 uM.
9 . The method of claim 1 , wherein a volume ratio of the nucleic acid samples and the qPCR reaction mixture is 1:60 to 1:10.
10 . The method of claim 1 , wherein the hybridization probe comprises a TaqMan probe, a molecular beacon probe, a dual-hybridization probe, or an Eclipse probe.
11 . The method of claim 1 , wherein the nucleic acid samples comprise a next-generation sequencing library.
12 . The method of claim 1 , wherein a concentration of the nucleic acid samples is 3 copies/μl to 30 copies/μl.Join the waitlist — get patent alerts
Track US2019112642A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.